Cooper Companies (COO) Stock Price, News & Analysis

Company Overview

The Cooper Companies (NASDAQ:COO) is a global medical device company that designs, manufactures and markets products in the vision care and women’s health fields. Headquartered in San Ramon, California, Cooper operates through two primary business segments: CooperVision, which focuses on the development of contact lenses and related ocular health products, and CooperSurgical, which provides a comprehensive portfolio of surgical instruments, fertility and gynecologic devices, and genetic and diagnostic solutions. Since its founding in the 1950s, the company has grown through both organic innovation and strategic acquisitions to become a leader in its core markets.

CooperVision offers a broad range of soft and rigid contact lenses, including daily disposables, toric lenses for astigmatism, multifocal lenses, and specialty products designed for keratoconus and other complex conditions. The segment invests heavily in research and development, utilizing advanced materials and digital technologies to enhance lens performance, oxygen permeability and wearer comfort. CooperVision supports eye care professionals with clinical education, research grants and patient-focused resources aimed at improving vision health outcomes.

CooperSurgical delivers an array of products and services across women’s health, fertility and genomic diagnostics. Its portfolio includes surgical instruments and devices for obstetrics and gynecologic procedures, in vitro fertilization (IVF) systems, fertility culture media, ultrasound imaging, and genetic screening tools. The segment also offers products for tissue diagnostics and oncology, along with customized support services for fertility clinics, hospitals and academic research centers. Through continuous innovation, CooperSurgical seeks to advance patient care and streamline clinical workflows.

With operations spanning the Americas, Europe, Asia-Pacific and selective emerging markets, The Cooper Companies maintains manufacturing facilities, R&D centers and sales offices around the world. Under the leadership of President and CEO Robert W. Weiss, the company emphasizes strategic partnerships, quality assurance and regulatory compliance. Cooper aims to address the evolving needs of healthcare providers and patients by combining its global scale with a decentralized approach to local market development and customer engagement.

Key Stats

• Today's Range: $74.62 to $75.93
• 50-Day Range: $66.91 to $84.44
• 52-Week Range: $65.00 to $112.38
• Volume: 2.52 million shs
• Average Volume: 1.74 million shs
• Market Capitalization: $14.95 billion
• P/E Ratio: 36.30
• Dividend Yield: N/A
• Price Target: $99.70
• Consensus Rating: Moderate Buy

Cooper Companies Stock Analysis - MarketRank™

Cooper Companies scored higher than 63% of companies evaluated by MarketBeat, and ranked 399th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Cooper Companies has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Cooper Companies has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 11.81%

Earnings Growth

Earnings for Cooper Companies are expected to grow by 11.81% in the coming year, from $3.98 to $4.45 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cooper Companies is 36.30, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.92.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cooper Companies is 36.30, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.10.

Price to Earnings Growth Ratio

Cooper Companies has a PEG Ratio of 1.87. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Cooper Companies has a P/B Ratio of 1.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.09% of the float of Cooper Companies has been sold short.

Short Interest Ratio / Days to Cover

Cooper Companies has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cooper Companies has recently increased by 2.89%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cooper Companies does not currently pay a dividend.

Dividend Growth

Cooper Companies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.09% of the float of Cooper Companies has been sold short.

Short Interest Ratio / Days to Cover

Cooper Companies has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cooper Companies has recently increased by 2.89%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: 0.91

News Sentiment

Cooper Companies has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 18 news articles for Cooper Companies this week, compared to 20 articles on an average week.

Search Interest

Only 4 people have searched for COO on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Cooper Companies to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cooper Companies insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.98% of the stock of Cooper Companies is held by insiders.

Percentage Held by Institutions

Only 24.39% of the stock of Cooper Companies is held by institutions.

COO Stock Analysis - Frequently Asked Questions

How have COO shares performed this year?

Cooper Companies' stock was trading at $91.93 at the start of the year. Since then, COO stock has decreased by 18.7% and is now trading at $74.77.

How were Cooper Companies' earnings last quarter?

The Cooper Companies, Inc. (NASDAQ:COO) issued its earnings results on Thursday, May, 29th. The medical device company reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. The company's revenue for the quarter was up 6.3% on a year-over-year basis.
Read the conference call transcript.

When did Cooper Companies' stock split?

Cooper Companies's stock split before market open on Tuesday, February 20th 2024.The 4-1 split was announced on Tuesday, February 20th 2024. The newly minted shares were distributed to shareholders after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the split would have 400 shares after the split.

Does Cooper Companies have any subsidiaries?

Cooper Companies subsidiaries include these companies: Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., Coopervision, CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, and others.

Who are Cooper Companies' major shareholders?

Cooper Companies' top institutional investors include Alecta Tjanstepension Omsesidigt (0.67%), Swedbank AB (0.59%), Assenagon Asset Management S.A. (0.12%) and Mn Services Vermogensbeheer B.V. (0.04%). Insiders that own company stock include Robert S Weiss, Albert G White III, Jody S Lindell, Daniel G Mcbride, Brian G Andrews, Gary S Petersmeyer, Gerard H Warner III and Agostino Ricupati.
View institutional ownership trends.

How do I buy shares of Cooper Companies?

Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cooper Companies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cooper Companies investors own include NVIDIA (NVDA), Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM) and Visa (V).

Company Calendar

• Last Earnings: 5/29/2025
• Today: 7/12/2025
• Next Earnings (Estimated): 8/27/2025
• Fiscal Year End: 10/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: Health Care Supplies
• Current Symbol: NASDAQ:COO
• Previous Symbol: NYSE:COO
• CIK: 711404
• Web: www.coopercos.com
• Phone: (925) 460-3600
• Fax: 925-460-3649
• Employees: 16,000
• Year Founded: 1958

Price Target and Rating

• Average Price Target for Cooper Companies: $99.70
• High Price Target: $115.00
• Low Price Target: $76.00
• Potential Upside/Downside: +33.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.73
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.06
• Trailing P/E Ratio: 36.30
• Forward P/E Ratio: 18.79
• P/E Growth: 1.87
• Net Income: $392.30 million
• Net Margins: 10.39%
• Pretax Margin: 15.80%
• Return on Equity: 9.60%
• Return on Assets: 6.35%

Debt

• Debt-to-Equity Ratio: 0.30
• Current Ratio: 2.10
• Quick Ratio: 1.23

Sales & Book Value

• Annual Sales: $3.90 billion
• Price / Sales: 3.84
• Cash Flow: $5.45 per share
• Price / Cash Flow: 13.72
• Book Value: $40.50 per share
• Price / Book: 1.85

Miscellaneous

• Outstanding Shares: 199,980,000
• Free Float: 196,021,000
• Market Cap: $14.95 billion
• Optionable: Optionable
• Beta: 0.99